H.R. 10763: Know Your Risk Act

This bill would direct the Department of Health and Human Services (HHS) to study breast cancer risk assessment tools and report its findings to Congress within 180 days of enactment.

What the report would cover

The report would identify:

• mistakes or inaccuracies that can happen when existing breast cancer risk tools are used;
• where and among which groups these tools are not being used as much as they could be; and
• what factors may be causing those inaccuracies and gaps in use.

Possible creation of a single public tool

The report would also outline the planning needed to create one comprehensive, publicly accessible breast cancer risk assessment tool. In addition, HHS would be asked to describe:

• how to make the public aware of such a tool;
• how to build agreement among patients, doctors, schools, health care organizations, for-profit and nonprofit groups, and other relevant entities; and
• how such a tool might be developed and used.

Changes to federal grant programs

The bill would amend parts of the Public Health Service Act related to breast and cervical cancer screening grants so that grant-funded programs would need to include:

• evidence-based breast cancer risk assessments;
• training and clinical use of validated risk assessment models;
• implementation of standardized risk assessment tools in appropriate clinical settings, including integration into electronic health record systems;
• public education about breast cancer risk factors, individual risk, genetic predisposition, and risk-reduction options; and
• research to improve the accuracy of existing risk models across racial, ethnic, geographic, and age groups.

New reporting requirements for states

States receiving certain federal breast cancer screening grants would have to report data to HHS on:

• how many people received risk assessments;
• how many and what percentage were found to be at elevated risk;
• how many were referred for enhanced screening, genetic counseling, preventive treatment, or other risk-reduction services; and
• differences in access to risk assessments and follow-up care across regions and underserved populations.

Relevant Companies

None found